معرفی
Professor Mark Lawler is an internationally recognized academic holding positions as Associate Pro-Vice-Chancellor and Professor of Digital Health at Queen's University Belfast. He leads the Patrick G Johnston Centre for Cancer Research and chairs the Translational Cancer Genomics department. His work focuses on cancer research, health data integration, and precision medicine, with a strong emphasis on translating research into clinical and policy impacts. Professor Lawler has pioneered initiatives like the European Cancer Patient’s Bill of Rights, adopted across 25 countries, and has influenced health policy through the 70:35 Vision for cancer survival rates. He also serves as Associate Director of Health Data Research Wales-Northern Ireland and Scientific Director of DATA-CAN, the UK Health Data Research Hub for Cancer.
- Education: While specific academic qualifications are not detailed, his 30+ years in cancer research and leadership roles indicate advanced training in oncology and biomedical sciences.
Research interests span colorectal cancer biology, health data analytics, and the societal impact of cancer. His recent work on the pandemic's effect on cancer care has garnered international attention, highlighting delays in diagnosis and potential future epidemics. He is a vocal advocate for patient involvement in research and public health advocacy.
Publications and projects include clinical trials on targeted therapies, systematic reviews on cancer screening, and policy-focused analyses. He has received the 2018 European Health Award and holds key roles in organizations like the European Cancer Organisation and the European Alliance for Personalised Medicine.
Professor Lawler mentors students and collaborates globally on initiatives like the Future Medicines Institute and the Global Innovation Institute. His leadership in health data integration aims to bridge gaps between research, clinical practice, and policy-making.
